Cherrystone Hill Capital Management LLC is an investment management firm offering services to individuals, businesses, institutions, and pooled investment vehicles.
Our primary focus is investing in the securities of listed healthcare companies that operate primarily in the world's emerging markets. We see four trends creating opportunities here:
- Growth in domestic demand — Healthcare spending in most of these countries is well below the global average, and should grow rapidly over time.
- Emergence of global exporters — A variety of emerging market-based companies have developed leading positions in their subsectors.
- Rising innovation — Life sciences R&D spending growth in emerging Asia is outpacing the developed world. These investments are just starting to bear fruit.
- Expanding investment options — Barriers to foreign investment in developing countries are declining. In addition, there is a broad range of healthcare businesses that are unique to the developing world.
The company is registered with the Massachusetts Securities Division as an investment adviser. Registration as an investment adviser does not imply any certain level of skill or training.
The firm is a member of the Kendall Square Association and the American Chamber of Commerce of China (AmCham China).
Developing World Healthcare Blog
Visit our Developing World Healthcare Blog for monthly postings on developments in healthcare in emerging and frontier markets. We have a
unique perspective as one of the few investment professionals with work in this field.
Chief Investment Officer
Our Chief Investment Officer has thirty years' of experience in the capital markets in a variety of roles as an institutional buy-side analyst/portfolio manager; sell-side analyst; and investment banker. In addition, he has lived and worked in both the US and Asia.